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Abstract: 
Studies on Gulf War veterans with depleted uranium (DU) fragments embedded in their soft tissues have led to 
suggestions of possible DU-induced neurotoxicity. We investigated DU uptake into cultured rat brain 
endothelial cells (RBE4). Following the determination that DU readily enters RBE4 cells, cytotoxic effects were 
analyzed using assays for cell volume increase, heat shock protein 90 (Hsp90) expression, 3-[4,5-dimethylth-
iazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT) reduction, and lactate dehydrogenase (LDH) activity. The 
results of these studies show that uptake of the U3O8 uranyl chloride form of DU into RBE4 cells is efficient, 
but there are little or no resulting cytotoxic effects on these cells as detected by common biomarkers. Thus, the 
present experimental paradigm is rather reassuring and provides no indication for overt cytotoxicity in 
endothelial cells exposed to DU. 
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Article: 
INTRODUCTION 
Depleted uranium (DU) is a component of military munitions and is therefore the subject of important toxicity 
studies. Specifically, the possibility of DU neurotoxicity is under investigation. DU is a dense heavy metal used 
without reserve in many military applications. Chemically similar to natural uranium, but depleted of much of 
the radioactivity of the 
235
U and 
234
U isotopes, DU is a low-specific-activity metal that has several advantages 
for use as weapons material. Neurotoxicity could potentially arise from the chemical or radioactive properties of 
DU, and the level of neurotoxicity is as yet undetermined (1–3). 
 
Gulf War veterans with DU fragments embedded in their soft tissues were studied and the results suggested that 
there might be DU-associated effects on behavior and cognition (1–4). Rats embedded with DU fragments 
accumulated uranium in a range of tissues, with early levels highest in the kidney and a gradual increase in bone 
accumulation. Brain tissues were found to have far lower levels, with the hippocampus showing high levels 
among the brain regions following physiologically relevant exposures and cerebellum accumulating the highest 
levels upon extremely high exposure levels (4,5). This group also reports electrophysiological changes in the 
hippocampus (5). There have been several recent summary reports concerning follow-ups on the Gulf War 
veterans, and although urine excretion levels remain high in some subjects, no nephrotoxicity has been found 
(1–3). However, hypoxanthine phosphoribosyl transferase (HPRT) gene mutation rates are elevated in subjects 
with high urinary uranium excretion (1). There is also the possibility of exposure resulting from inhaled DU 
dust from munitions impact (6). 
 
For a blood-borne contaminant to cause neurotoxicity, it must first cross the blood–brain barrier (BBB). This 
barrier protects the central nervous system (CNS) from toxicants in the blood, and its ability to protect against 
metal neurotoxicity was reviewed by Zheng et al. (7). The capillaries of the brain are lined with endothelial cells 
acting as the first line of defense in the BBB. The high degree of tightness of the junctions that link the 
endothelial cells virtually prevents any paracellular passage from occurring in physiological conditions. In 
addition, several transport proteins can increase the brain-to-blood efflux of various compounds (e.g., P-
glycoproteins or multidrug resistance proteins [MDR] of the ATP-binding cassette [ABC]) (7). The molecular 
details of uranium transport across the BBB are completely unknown, but Lemercier et al. have investigated the 
process through an in situ unilateral brain perfusion technique (8). They report significantly higher uranium in 
the parenchyma of the exposed hemisphere, indicating that DU does cross the BBB. We have studied RBE4 rat 
brain endothelial cells for transport of other metals (9), and the divalent metal transporter (DMT- 1) is a likely 
putative candidate for the transport of DU into endothelial cells and across the BBB. This transporter has an 
unusually broad substrate range that includes Fe
2+
, Zn
2+
, Mn
2+
, Co
2+
, Cd
2+
, Cu
2+
, Ni
2+
, and Pb
2+
, and it is 
plausible that it mediates uranium transport into the CNS (10,11). If DU does enter endothelial cells, the toxicity 
it causes to these cells is also completely unknown. 
 
The rat brain endothelial cell line (RBE4) was derived from rat brain microvascular endothelial cells 
immortalized with the plasmid pE1A-neo, containing the E1A region of adenovirus 2 and a neomycin-
resistance gene (12,13). RBE4 cells preserve the endothelial phenotype, show differentiation characteristics of 
brain endothelium in the presence of glial factors, and express P-glycoprotein (14,15). We report in this study 
the uptake of DU into RBE4 cells and three biochemical indicators of cell toxicity following the DU exposures. 
These include induction of a heat shock protein (Hsp90), a stress response indicator known to increase with 
many heavy metal exposures, lactate dehydrogenase (LDH) release, which demonstrates loss of cell membrane 
integrity, and 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide (MTT) conversion to formazan, 
which is primarily an indicator of normal mitochondrial function. 
 
MATERIALS AND METHODS  
Culture and Treatment of RBE4 Cells 
The RBE4 cell line was provided as a gift from Neurotech, S.A. (Evry, France). Cells of passage 20–80 were 
grown on collagen-coated tissue culture flasks (Becton Dickinson Labware, UK). The RBE4 cells were main-
tained in medium of the following composition: 1 : 1 Ham’s F10/minimum essential medium (MEM) 
supplemented with 10% fetal calf serum (FCS), basic fibroblast growth factor (bFGF, 1 ng/mL), and Geneticin 
(300 µg/mL). For the present experiments, these cells were treated with depleted uranium in the oxidized form 
of U3O8 uranyl chloride diluted in HEPES buffer to final concentrations of 10, 50, or 100 µM or HEPES buffer 
alone. 
 
Uranium Uptake Assay Using RBE Monolayer and Neutron Activation Analysis 
RBE4 cells were pretreated with HEPES alone or 100 µM deferoxamine (DFO) in HEPES for 30 min at 37°C, 
and then they were treated with HEPES or U3O8 uranyl chloride dissolved in HEPES buffer at concentrations of 
10 or 50 µM for either 15 or 30 min at 37°C. The cells were washed four times with ice-cold mannitol buffer 
(290 mM mannitol, 10 mM Trisnitrate, 0.5 mM Ca(NO3)2, pH 7.4) and then lysed with 1 N NaOH for 10 min. 
Aliquots of 0.75 mL were then frozen for shipment to North Carolina State University for neutron activation 
analysis (16). 
 
HSP90 Induction 
Western blots were performed using protein samples from RBE4 cells treated with control media or 10 or 100 
µM DU for 10 min, 30 min, or 1 h. The cells were then washed three times with cold phosphate-buffered 
saline (PBS). Subsequently, the cells were harvested with PBS/0.5 mM EDTA and immediately centrifuged at 
12,000g for 10 min. The supernatant was removed and the remaining pellet was resuspended in WANG buffer 
(25 mM HEPES, pH 7.0, 250 mM sucrose, 100 µM EDTA, 1 µg/mL leupeptin, 0.5 µg/mL pepstatin A, 1 mM 
dithiothreitol [DTT], 0.2% Triton-X 100). Following sample sonication, the protein content was determined 
using the bicinchoninic acid (BCA) method (Pierce, Rockford, IL). Aliquots of protein (100 µg) were mixed 
with 5X sample buffer (0.25 M Tris-HCl, pH 6.8, 10% sodium dodecyl sulfate [SDS], 50% glycerol) and 1 M 
DTT and separated by denaturing SDS-PAGE (Polyacrylamide gel electrophoresis using 5% stacking and 8% 
resolving acrylamide gels. Proteins were electrophoretically transferred to a nitrocellulose membrane (Protran 
BA83; Schleicher and Schuell, Keene, NH) in 20% methanol, 0.1% SDS, 25 mM Tris-HCl, and 192 mM 
glycine for 3 h at 60 V. Membranes were then blocked with 5% nonfat powdered milk in TBST (Tris-buffered 
saline with 0.1% Tween-20, 150 mM NaCl; 20 mM Tris-HCl) for 1 h. Hsp90 protein expression was detected 
with a rabbit monoclonal antibody (Alpha Diagnostic International, San Antonio, TX) diluted 1 : 2500 in TBST 
and 5% milk overnight, followed by a 1-h incubation with an horseradish perocidase (HRP)-conjugated anti-
rabbit secondary antibody (1 : 5000). Protein bands were visualized with the Enhanced Chemiluminescence 
System (New England Nuclear; Boston, MA), followed by exposure to X-ray film. Films were digitized and 
band density was determined using the TINA v2.09e program (Raytest USA, Inc., Wilmington, NC). 
 
Volume Measurements in RBE4 Cells Treated with DU 
The RBE4 cell volume was determined by modification of the electrical impedance method (17). Cell 
monolayers grown on a No. 1.5 cover slip were placed in a channel that joins two chambers. The total height of 
the channel was approx 250 µm. Each chamber contained a silver wire electrode (5 cm in length) that was 
soldered at the distal end to a copper-insulated wire for connection through a large resistance (1 MΩ), to a lock-
in amplifier that supplied a 500-Hz, 5-V signal to the system. There was a continuous flow of solution through 
the channel (1 mL/min). As the volume of the cell monolayer increased, the volume of the solution within the 
channel and above the cells available for current flow decreased proportionately, resulting in an increase in the 
measured resistance in the channel above the cells. Because V=IR (where V is voltage, I is current, and R is 
resistance) and I was kept constant, changes in V are directly proportional to changes in R. 
 
The monolayer of RBE4 cells was bathed in a HEPES-buffered solution consisting of the following: 122 mM 
NaCl, 3.3 mM KCl, 0.4 mM MgSO4, 1.3 mM CaCl2, 1.2 mM KH2PO4, 10 mM D(+) glucose, 25 mM HEPES. 
All buffers were adjusted to pH 7.4 by addition of 10 N NaOH. The osmolarity of the isotonic solution was 
approx 300 mOsmol as measured by a freezing-point osmometer (Advanced Instruments, Inc., Needham 
Heights, MA). The protocol for all experiments involved a 15-min exposure to isotonic buffer, followed by a 
60-min exposure to isotonic buffer containing various concentrations of U3O8 (0–100 µM). 
 
LDH Toxicity Assay 
The RBE4 cells in 96-well culture plates were treated with 10 or 50 µM U3O8 in HEPES buffer or HEPES alone 
at 37°C for 3 or 6 h. The treatment media was removed and the CytoTox96 Non-Radioactive Cytotoxicity assay 
for lactate dehydrogenase (LDH) activity (Promega) was employed to assess differences between LDH content 
of the samples. The cells were lysed and combined with the LDH substrate according to the manufacturer’s 
recommendations. The assay for total LDH utilizes colorimetric measurement for conversion of a tetrazolium 
salt (INT) into a red formazan product at 490 nm in a spectrophotometric 96-well plate reader. Toxic metals 
effectively remove some of the cellular LDH by inducing events of toxicity, including loss of cell membrane 
integrity. Therefore, total LDH activity is effectively reduced in those samples treated with toxic metals. 
Treated samples are reported as percentage of control sample viability. 
 
MTT Toxicity Assay 
The CellTiter96 Aqueous One Solution Cell Proliferation assay for MTT reduction to formazan (Promega) was 
also used to assess cells treated with 10 or 50 µM U3O8 in HEPES buffer or HEPES alone at 37°C for 3 or 6 h. 
MTT reagent was then added to the cells and further incubated at 37°C before colorimetric measurement for 
substrate conversion at 490 nm in a spectrophotometric 96-well plate reader, according to the manufacturer’s 
recommendations. Toxicity results in decreased ability to reduce MTT to formazan. Treated samples are 
reported as percentage of control sample viability. 
 
RESULTS 
Heavy metals can be toxic to mammalian cells in culture at relatively low doses. This study focuses on 
concentrations of DU in the potential physiological range, according to previous reports (1–3). Concentrations 
of 10 µM, 50 µM, and, in some cases, 100 µM U3O8 were used for RBE4 treatments in the following studies. 
 
Uptake of DU into RBE4 cells 
Depleted uranium in HEPES buffer readily entered cultured RBE4 endothelial cells as measured by neutron 
activation analysis (NAA) (16). Cultured RBE4 cells were pretreated with HEPES-only control buffer for 30 
min. To investigate other possible influences on cellular uptake of DU, additional samples were pretreated with 
100 µM DFO to chelate iron. Following removal of pretreatment media, cells were next treated with DU-
containing HEPES or HEPES-only control buffer for 15 or 30 min. Cells were then rinsed, collected, pelleted, 
and frozen for NAA. Time-points of 15 and 30 min after replacement of normal culture media with DU-con-
taining HEPES or HEPES-only control buffer are shown in Fig. 1. All DU-treated samples showed between 
0.27 and 0.4 µg U3O8/µg protein analyzed. No differences were observed between 15-min and 30-min expo-
sures, and DFO showed no effect on uptake. These data demonstrate rapid entry of DU into the cells. 
 
 
Effects of DU on Hsp90 Expression in RBE4 Cells 
Western blot techniques were used to assess the ability of U3O8 to alter Hsp90 expression in RBE4 cells. As 
shown in Fig. 2, U3O8 caused a small but significant (p < 0.05) increase in Hsp90 levels at 10 and 30 min (100 
and 10 µM, respectively) compared to control treated RBE4 cells, but this effect was not apparent after 1 h (note 
y-axis represents percent change over control, which is standardized to 100%). Accordingly, we conclude that 
any effect of U3O8 is fast and short-lasting, and the consequences should be investigated for further detail in 
future studies. 
 
Volume Measurements in RBE4 Cells Treated with DU 
Volume changes are expressed as change in voltage. RBE4 cells were treated with 10, 50, or 100 µM DU 
(U3O8) and monitored for cell volume changes for 30 min. As can be noted in Fig. 3, the maximal change in 
voltage was an increase from approx 140 mV for controls to 140.75 mV in RBE4 cells treated with 100 µM 
U3O8. This translates to about a 0.5% change in cell volume (17). Because a 1% change in volume in our system 
approximates a 25% change in cell volume (assuming cellular cell height of 4 µM), we conclude from these 
experiments that U3O8 does not cause a drastic change in cell volume over the 30-min exposure period. Thus, 
RBE4 cells are capable of withstanding a high exposure to DU without a discernable change in cellular volume. 
 
 
LDH and MTT Cytotoxicity Assays 
The assays for LDH activity and MTT activity are widely utilized as indicators of cytotoxicity. Both 
demonstrated that 10 or 50 µM U3O8 causes little or no toxicity to the RBE4 cells (Fig. 4). Additionally, caspase 
assays showed no induction of caspases 8 or 9 following U3O8 exposure (data not shown). 
 
DISCUSSION 
The possibility of DU transport to the brain from soft tissues embedded with DU fragments poses considerable 
concern. Based on the previous reports of increased DU levels in the brain tissue of rats with DU fragments 
embedded in the muscles of their extremities, we would expect efficient uptake into endothelial cells (4,5,7). 
Our studies confirm this; however, we also show that despite the elevated level of uranium taken up by these 
cells, toxicity measured by several biochemical indicators is minimal. A report by Kalinich et al. showed DU 
induction of apoptosis in mouse macrophages (18). Another recent study reported that in HepG2 cells, DU 
induced some changes in gene expression, including positive results for 10 different stress-related genes (19). 
By contrast, we found little or no evidence of DU toxicity to rat brain endothelial cells using four different 
assays. 
 
The 90-kDa heat shock protein (Hsp90) is one of the most abundant proteins in cells, constituting 1–2% of total 
intracellular protein. It is constitutively and ubiquitously expressed and is the most abundant molecular 
chaperone of the eukaryotic cytoplasm. Chaperones help to achieve and maintain the conformational status of 
cellular proteins and enzyme complexes. By influencing higher-order protein structure, Hsp90 is involved in 
the conformational regulation of key proteins in multiple signaling pathways, including nitric oxide synthases 
(NOS), kinases, phosphatases, and steroid hormone receptors. Hsp90 regulates the redox status of other proteins 
by assisting in the formation and breakage of disulfide bridges. The importance of Hsp90 interactions in the 
promulgation of neurotoxicity is incompletely understood, but its induction is a well-known stress response to 
treatment of cultured cells with heavy metals (20). Our data show slight inductions in Hsp90 at the earlier time-
points of 10 and 30 min following exposure to 100 and 10 µM DU, respectively. However, 1 h after exposure, 
there was no detectable difference between DU samples and controls. Considering the recent report of Prat et al. 
(21), in which Hsp90 was found to be downregulated in HEK293 cells by DU exposure, there might be a dif-
ferential Hsp90 response depending on cell type and duration of exposure. 
 
Cell volume change is a stress response that is found after heavy metal exposure, among other insults (17,22). 
We detected minimal volume change in RBE4 cells following DU exposures that was indistinguishable from 
controls, even when the concentration of uranium was increased to 100 µM. By comparison, other heavy metals 
induce much larger cell volume changes (23). 
 
Metabolically active cells are able to reduce the commercially marketed tetrazolium compound Owen’s reagent 
(MTS) into formazan, presumably through NADPH or NADH. This reagent is therefore a good indicator of cell 
viability, especially as it relates to mitochondrial function (24,25). The release of LDH upon cell lysis is another 
widely used and commercially available indicator of cell viability (26). Our data show that there was no 
evidence of any loss of mitochondrial function or LDH release, once again indicating high viability following 
DU treatment. 
 
A very recent report described rats exposed to DU in their drinking water that showed significant behavioral 
changes (27). There was also some evidence of lipid peroxidation in the brain. Interestingly, the authors also 
noted more behavioral effects in male rats than female. These results suggested that, at least in rats, the DU that 
crosses the BBB has neurological effects. Further studies are merited to determine the effects in humans. 
We conclude here that rat brain endothelial cells show efficient uptake of DU. Considering the ease with which 
DU entered RBE4 cells, the astrocytes beyond the endothelial layer are presumably also exposed to comparable 
levels of DU. Studies similar to those reported here are currently being conducted to investigate the responses of 
astrocytes to such exposure. Overall, these studies indicate that exposure of endothelial cells to DU does not 
profoundly affect their function. Whether more subtle effects are inherent to this type of exposure has yet to be 
determined. 
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